The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 5, 1999, Pages 1104-1109

  Fox, John ^a,b,e   Remington, Patrick ^a   Layde, Peter ^c   Klein, Gail ^d  

^a WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d Dane County Cytology Center Inc   (United States)

^e Physicians Plus Insurance Corporation   (United States)

Author keywords

Hysterectomy; Papanicolaou smear; Screening; Vaginal cytology

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CARCINOMA; CASE CONTROL STUDY; CONTROLLED STUDY; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SCREENING; UTERINE CERVIX; VAGINA CYTOLOGY;

EID: 0033038831     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70601-0     Document Type: Article

References (20)

1. 1. Fetters MD, Fischer G, Reed BD. Effectiveness of vaginal Papanicolaou smear screening after total hysterectomy for benign disease. JAMA 1996;275:940-7.
2. 2. Miller AB, Anderson G, Brisson J, et al. Report of a national workshop on screening for cancer of the cervix. Can Med Assoc J 1991;145:1301-25.
3. 3. US Preventive Services Task Force. Screening for cervical cancer. In: US Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Baltimore: Williams and Wilkins; 1996. p. 105-17.
4. 4. National Cancer Institute. What you need to know about cancer of the cervix. Bethesda: US Dept. of Health and Human Services, National Institutes of Health; 1991.
5. 5. American Cancer Society. Pap test. Atlanta: The Society; 1991.
6. 6. American College of Obstetricians and Gynecologists. Recommendations on the frequency of Pap smear screening. Washington: The College; 1995. p. 112. ACOG Committee Opinion.
7. 7. Pokras R, Hufnagel VG. Hysterectomy in the United States, 1965-1984. Am J Public Health 1988;78:852-3.
8. 8. Wilcox LS, Koonin LM, Pokras R, et al. Hysterectomy in the US, 1988-90. Obstet Gynecol 1994;83:549-55.
9. 9. Leninger L. Overperformance of preventive care procedures in primary care practice [abstract]. J Gen Intern Med. 1994;9:88.
10. 10. Kvale KM, Remington PL, Lantz PM. Self-reporting of Pap smear tests among women after hysterectomy. Wis Med J 1994:275-6.
11. 11. Wheat ME, Mandelblatt JS, Kunitz G. Pap smear screening in women 65 and older. J Am Geriatr Soc 1988;36:827-30.
12. 12. Muller C, Mandelblatt J, Schecter CB, et al. The costs and effectiveness of cervical cancer screening in elderly women: series on preventive health services under Medicare. Washington: Office of Technology Assessment; 1990. Paper No.: 4.
13. 13. Kurman RJ, Solomon D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. New York: Springer Verlag; 1994.
14. 14. Schlesselman JJ. Case-control studies. New York: Oxford University Press; 1982.
15. 15. Pearlstone AC, Grigsby PW, Mutch DG. High rates of atypical cervical cytology occurrence and clinical significance. Obstet Gynecol 1992;80:191-5.
16. 16. Piscitelli JT, Bastian LA, Wilkes A, Simel DL. Cytologic screening after hysterectomy for benign disease. Am J Obstet Gynecol 1995;173:424-32.
17. 17. Miller JM, Chambers DC, Miller JM. The need for Pap tests after hysterectomy for benign disease: results of a study of black patients. Postgrad Med 1987;82:200-2, 5.
18. 18. Pearce KF, Haefner HK, Sarwar SF, Nolan TE. Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med 1996;335: 1559-62.
19. 19. Fisher G, Fetters MD, Ruffin MT. Vaginal smears after hysterectomy. J Fam Pract 1995;41:16-7.
20. 20. Noller KL. Screening for vaginal cancer. N Engl J Med 1996;335:1599-600.